446 related articles for article (PubMed ID: 31115372)
1. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
3. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
[TBL] [Abstract][Full Text] [Related]
4. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
5. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
7. [Transfusion and alloimmunization in sickle cell anemia patients].
Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
9. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria.
Ugwu NI; Awodu OA; Bazuaye GN; Okoye AE
Niger J Clin Pract; 2015; 18(4):522-6. PubMed ID: 25966726
[TBL] [Abstract][Full Text] [Related]
10. RBC alloimmunization and double alloantibodies in thalassemic patients.
Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
[TBL] [Abstract][Full Text] [Related]
11. Molecular genotyping of clinically important blood group antigens in patients with thalassaemia.
Kulkarni S; Choudhary B; Gogri H; Patil S; Manglani M; Sharma R; Madkaikar M
Indian J Med Res; 2018 Dec; 148(6):713-720. PubMed ID: 30778005
[TBL] [Abstract][Full Text] [Related]
12. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
[TBL] [Abstract][Full Text] [Related]
13. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
[TBL] [Abstract][Full Text] [Related]
14. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Ameen R; Al Shemmari S; Al-Bashir A
Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
[TBL] [Abstract][Full Text] [Related]
16. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Ang AL; Lim CY; Ng WY; Lam JCM
Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
18. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
Lasalle-Williams M; Nuss R; Le T; Cole L; Hassell K; Murphy JR; Ambruso DR
Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia.
Al-Asmari B; Baothman A; Almohammadi M; Aljuaid M; Jastaniah W
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e284-e289. PubMed ID: 38857199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
